Programmable antigen-presenting scaffolds expand rare tumor-antigen-specific T cells from peripheral blood
Adoptive cellular therapies can be effective against solid tumors but rely on the identification and expansion of rare tumor-reactive T cells (TRTs). Here, we utilize antigen-presenting cell-mimetic scaffolds (APC-ms), a modular biomaterial platform that presents defined peptide-HLA and co-stimulatory ligands on a fluid lipid bilayer to selectively recover rare antigen-specific T cells from…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
